domingo, 15 de noviembre de 2026
BuscarExplore
es.via.news
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 18, 2026

JPMorgan has stark message on Qualcomm stock

View original at finance.yahoo.com
JPMorgan has stark message on Qualcomm stock JPMorgan is becoming more cautious on QUALCOMM Incorporated (QCOM) ahead of its upcoming earnings report, citing rising pressure in its core handset business…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Fiscal Q2 2026 non-GAAP EPS guidance of $2.45 to $2.65

    60% confidence

  • Qualcomm's stock may not be cheap relative to normalized earnings power if handset weakness persists

    60% confidence

  • Fiscal Q2 2026 revenue guidance of $10.2 billion to $11.0 billion

    60% confidence

  • Rising pressure in Qualcomm's core handset business with newer growth areas not yet large enough to offset weakness

    60% confidence

  • Meaningful near-term downside risk with no clear event likely to improve the outlook for Qualcomm

    60% confidence

  • QCT EBT margin guidance of 26-28% for fiscal Q2 2026, down from 31% previously

    60% confidence

  • QCT revenue expected to decline 22% in calendar 2026

    60% confidence

Data points we hold from this source

Qualcomm Incorporated · price target140 USD
Qualcomm Incorporated · previous price target185 USD
Qualcomm Incorporated · eps guidance low2.45 USD
Qualcomm Incorporated · eps guidance high2.65 USD
Qualcomm Incorporated · eps3.50 USD
Qualcomm Incorporated · revenue guidance high11.0 USD
Qualcomm Incorporated · revenue guidance low10.2 USD
Qualcomm Incorporated · consensus revenue12.21 USD
Qualcomm Incorporated · consensus eps3.39 USD

Citado en estos reportajes de Via News

Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,995
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,995 hechos verificados con la fuente5,580 documentos fuente archivados
Consulta estos datos → isubstrate.com
JPMorgan has stark message on Qualcomm stock — Source | Via News | es.via.news